Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple office procedure replace surgery for early miscarriage care?

NCT ID NCT07732231

Symptom relief Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial compares two ways to surgically manage a first-trimester miscarriage: manual vacuum aspiration (MVA) done in a clinic with local anesthesia, versus electric aspiration (EA) performed in an operating room under general anesthesia. Researchers want to see if the outpatient approach is just as effective and less costly, while maintaining patient quality of life. The study involves 860 women aged 18 to 44 with a confirmed miscarriage needing surgical treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Manual vacuum aspiration (MVA) performed in consultation under local anesthesia versus electric aspiration (EA) in the operating room under general or regional anesthesia.
What this could lead to
If MVA proves as effective and less costly, it could become the standard, more accessible option for managing early miscarriage.
What could go wrong
This is a cost-effectiveness study, not a test of a new drug; results depend on real-world implementation and patient preferences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 860 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Oct 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 44 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female, aged 18-44 years * Ultrasound-confirmed first-trimester miscarriage requiring surgical management * Gestational age between 5 and 12 weeks of amenorrhea * Incomplete spontaneous abortion or ongoing non-viable pregnancy * Patient able to provide oral informed consent Exclusion Criteria: * Complete expulsion of pregnancy (endometrial thickness \< 15 mm) * Choice of medical treatment with misoprostol * Elective termination of pregnancy * Unwanted pregnancy * Pregnancy of unknown location, molar pregnancy * Known uterine malformation * Prior surgical aspiration for the current pregnancy * Intrauterine device in place * Contraindicating medications (e.g. anticoagulants) * Protected adults (under guardianship) * Inability to complete study questionnaires * Lack of social security coverage * Haemorrhagic miscarriage

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for First trimester pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abortion, Spontaneous pregnancy disorder with abortive outcome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

First trimester pregnancy Miscarriage Pregnancy loss

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Nantes

    Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.